GYL Financial Synergies’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $7.08M | Sell |
35,868
-1,233
| -3% | -$243K | 0.53% | 46 |
|
|
2024
Q2 | $6.36M | Buy |
37,101
+359
| +1% | +$61.6K | 0.49% | 51 |
|
|
2024
Q1 | $6.69M | Buy |
36,742
+2,627
| +8% | +$478K | 0.52% | 47 |
|
|
2023
Q4 | $5.29M | Sell |
34,115
-642
| -2% | -$99.5K | 0.44% | 57 |
|
|
2023
Q3 | $5.18M | Sell |
34,757
-315
| -0.9% | -$47K | 0.5% | 50 |
|
|
2023
Q2 | $4.73M | Buy |
35,072
+19,761
| +129% | +$2.66M | 0.43% | 55 |
|
|
2023
Q1 | $2.44M | Buy |
15,311
+4,942
| +48% | +$788K | 0.29% | 70 |
|
|
2022
Q4 | $1.68M | Buy |
10,369
+318
| +3% | +$51.4K | 0.36% | 44 |
|
|
2022
Q3 | $1.35M | Buy |
10,051
+72
| +0.7% | +$9.66K | 0.37% | 41 |
|
|
2022
Q2 | $1.53M | Sell |
9,979
-770
| -7% | -$118K | 0.42% | 36 |
|
|
2022
Q1 | $1.74M | Sell |
10,749
-2,540
| -19% | -$412K | 0.42% | 29 |
|
|
2021
Q4 | $1.8M | Buy |
13,289
+405
| +3% | +$54.8K | 0.49% | 35 |
|
|
2021
Q3 | $1.39M | Buy |
12,884
+189
| +1% | +$20.4K | 0.71% | 26 |
|
|
2021
Q2 | $1.43M | Buy |
12,695
+1,302
| +11% | +$147K | 0.74% | 24 |
|
|
2021
Q1 | $1.23M | Sell |
11,393
-456
| -4% | -$49.4K | 0.68% | 28 |
|
|
2020
Q4 | $1.27M | Sell |
11,849
-93
| -0.8% | -$9.97K | 0.73% | 28 |
|
|
2020
Q3 | $1.05M | Buy |
11,942
+146
| +1% | +$12.8K | 0.69% | 29 |
|
|
2020
Q2 | $1.16M | Sell |
11,796
-901
| -7% | -$88.5K | 0.84% | 26 |
|
|
2020
Q1 | $967K | Buy |
12,697
+92
| +0.7% | +$7.01K | 0.62% | 31 |
|
|
2019
Q4 | $1.12M | Buy |
12,605
+635
| +5% | +$56.2K | 0.49% | 40 |
|
|
2019
Q3 | $906K | Buy |
11,970
+393
| +3% | +$29.7K | 0.45% | 44 |
|
|
2019
Q2 | $842K | Buy |
11,577
+166
| +1% | +$12.1K | 0.45% | 45 |
|
|
2019
Q1 | $920K | Sell |
11,411
-104
| -0.9% | -$8.39K | 0.52% | 41 |
|
|
2018
Q4 | $1.06M | Buy |
+11,515
| New | +$1.06M | 0.77% | 23 |
|